Genmab Presentations & Investor Relations material

Founded in 1999, Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.

genmab.com

Genmab presentations

42nd Annual J.P. Morgan Healthcare Conference image

42nd Annual J.P. Morgan Healthcare Conference

Genmab logo
Genmab